NASDAQ

Denali Therapeutics Inc. (DNLI)

♥ 680 Thanks from members

Live price chart, market sentiment, and community perspectives for Denali Therapeutics Inc. (NASDAQ: DNLI).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Marc Tessier-LavigneFounder: Arnon RosenthalFounder: Ryan WattsLeadership: Ryan Watts (CEO)Holder: BiogenHolder: Vanguard GroupHolder: BlackRock Inc.LRRK2 InhibitorsTREM2 AgonistsBlood-Brain Barrier Therapeutics#DNLI#Denali Therapeutics#Neurodegeneration#Biotech#Clinical Research